Сравнение
Ecnoglutide vs. Petrelintide
Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.
Идентичность
Категория
Метаболизм
Метаболизм
Номер CAS
нет данных
нет данных
Молекулярная масса
нет данных
нет данных
Период полувыведения
144 h
нет данных
Последовательность
нет данных
нет данных
Механизм действия
Ecnoglutide
Ecnoglutide is a modified GLP-1(7-37) peptide with an alanine-to-valine substitution at position 8 and an 18-C fatty-acid conjugation at the lysine-30 side chain. It is a so-called biased agonist: at the GLP-1 receptor it preferentially induces cAMP formation while β-arrestin recruitment is reduced. In preclinical models this has been linked to lower receptor internalisation and desensitisation. GLP-1 receptor activation is mechanistically associated with enhanced glucose-dependent insulin secretion, delayed gastric emptying and satiety signalling. The fatty-acid conjugation enables weekly administration via albumin binding.
Petrelintide
As an amylin analogue, petrelintide acts through amylin receptors, promoting satiety and slowed gastric emptying — a satiety pathway independent of the GLP-1 axis.
Доказательная база
Наивысшая доказательность
РКИ на людях
РКИ на людях
Исследования
5
1
из них на людях
5
1
Зафиксированные эффекты
4
2
Открытые противоречия
0
0
Задокументированные нежелательные явления
1
1
Правовой статус
Полные записи
Frequently asked questions
- What is the difference between Ecnoglutide and Petrelintide?
- Ecnoglutide is classified as "Метаболизм", while Petrelintide is classified as "Метаболизм". Ecnoglutide: Ecnoglutide (XW003) is a long-acting, cAMP-signalling-biased GLP-1 analogue from Sciwind Biosciences. Derived from GLP-1(7-37) with an alanine-to-valine substitution at position 8, it activates the GLP-1 receptor selectively via the cAMP pathway over β-arrestin recruitment. Investigated for weight management and in type 2 diabetes. Petrelintide: Petrelintide is a long-acting amylin analogue (Zealand Pharma, with Roche) for once-weekly subcutaneous use — developed for weight management with a focus on strong tolerability. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Ecnoglutide or Petrelintide?
- The highest available evidence level is "РКИ на людях" for Ecnoglutide and "РКИ на людях" for Petrelintide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Ecnoglutide and Petrelintide in Germany and the United States?
- Германия: Ecnoglutide — Не одобрено, Petrelintide — Не одобрено. США: Ecnoglutide — Не одобрено, Petrelintide — Не одобрено. These are factual summaries with source and review date on the individual pages.